Busan IFC Mall (2F–4F) · 6,600㎡ One-Day Comprehensive Health Screening & Specialist Care · International Patient Concierge

5.0 Verified Patient Rating

en-US

Yonsei Mirae IFC Medical Center LogoYonsei Mirae IFC Medical CenterHome
Book Consultation
Book Consultation
Patient Guide
SpecialtiesServicesDoctorsOffersArticlesPressReviewsAbout UsContact Us
Women's Health Screening in Busan: A Practical Guide

Medical Guide

Women's Health Screening in Busan: A Practical Guide

How breast, thyroid, and gynecologic screening fit into a single women's health checkup in Busan, South Korea, with guidance from USPSTF, ACOG, and ATA.

Schedule a Consultation

Women's Health Screening in Busan: Breast, Thyroid, and Gynecologic Checkup Options

Medically reviewed by Dr. Hwang Yeonhee, Obstetrics and Gynecology Specialist

A women's health checkup in Korea is rarely a single test. In practice it is three different conversations that happen to be scheduled on the same morning: one about the breast, one about the thyroid, and one about gynecologic and reproductive health. Each has its own evidence base, its own recommended starting age, and its own set of trade-offs. When breast and thyroid screening in Busan is bundled with a gynecologic consultation, the appeal is obvious. You walk in once, you answer the same history questions once, and you leave with a coordinated picture rather than three appointments spread across three months.

This guide explains what sits inside that bundle, what the major medical bodies actually recommend for each component, and how the pieces are assembled at Yonsei Mirae IFC Medical Center in Busan, South Korea. It is written for readers deciding whether a combined women's screening visit is worth planning around, and what questions to ask before they book one.

Why Women's Screening Gets Bundled in the First Place

The three components share very little biology. They share logistics. Breast imaging, thyroid assessment, and gynecologic evaluation all tend to be recommended on overlapping schedules for adult women, all benefit from being interpreted together with basic blood work, and all become harder to complete when each one requires a separate referral, a separate facility, and a separate waiting period.

A bundled visit compresses that. It also creates a single point where a clinician can look at the whole picture at once — the mammogram, the neck ultrasound, the thyroid blood panel, and the gynecologic history — rather than reading each result in isolation.

There is a caution worth stating up front. More tests are not automatically better tests. Every screening examination carries a chance of a finding that turns out to be harmless but still generates follow-up imaging, anxiety, and sometimes a needle. A well-designed women's screening visit is one where each component was chosen for a reason, not one where every available box was checked.

Breast Screening: What the Major Bodies Recommend

Breast cancer screening is the most heavily studied component of any women's checkup, and it is also the one where respected organizations reach slightly different conclusions from the same evidence.

The U.S. Preventive Services Task Force updated its breast cancer screening statement in 2024 and now recommends mammography every two years for women aged 40 through 74, a change from its earlier position, which set the routine starting age at 50 for most women. The Task Force grades this as a B recommendation, meaning it judges the net benefit to be moderate rather than overwhelming.

The American Cancer Society reaches a different arrangement of the same idea. Its guideline for women at average risk describes the years from 40 to 44 as an option period, during which a woman may choose to begin annual mammography; recommends annual screening from 45 through 54; and then offers a transition to screening every two years from 55 onward, with the option to continue annually.

The practical takeaway is not that one body is right. It is that between roughly 40 and 55, the starting age and the interval are legitimately a matter of individual preference and individual risk — family history, breast density, previous biopsy results, and how you personally weigh the possibility of a false alarm against the possibility of an earlier catch.

How Breast Imaging Is Handled at the Busan Center

Yonsei Mirae IFC Medical Center groups its breast work under a Breast and Thyroid Care service line, which covers three things: AI-Assisted 3D Mammography Screening, Breast and Thyroid Ultrasound, and Breast and Thyroid Biopsy. The mammography equipment is a Hologic Selenia Dimensions system with AI-assisted computer-aided detection support.

The center's documented breast pathway begins with a health questionnaire and medical-history review, moves to a physician or screening assessment, then to breast imaging with mammography and ultrasound when indicated, then to radiologic and laboratory interpretation, and finally to an explanation of findings and any follow-up. Ultrasound is used as a complementary examination rather than a substitute — the two modalities show different kinds of findings, which is why they are often paired, particularly when breast tissue is dense.

A few practical notes for the day itself. Mammography compresses the breast to obtain diagnostic images, so temporary pressure or tenderness is normal and usually settles without treatment. You should avoid applying deodorant, powder, or lotion around the breasts and underarms that morning, because these products can create artifacts on the image that resemble calcifications. Tell the team about pregnancy, breastfeeding, implants, previous breast surgery, or a previous abnormal mammogram — mammography is not performed during breastfeeding, and breast ultrasound is used instead in that situation.

Thyroid Screening: Function and Structure Are Two Different Questions

Thyroid assessment confuses people because the word covers two entirely separate examinations that answer separate questions.

The first is function: is the gland producing the right amount of hormone? The National Institute of Diabetes and Digestive and Kidney Diseases explains that clinicians usually measure thyroid-stimulating hormone first, because TSH is the pituitary signal that tells the thyroid how much T4 and T3 to make. A high TSH generally points toward an underactive thyroid and a low TSH toward an overactive one, and NIDDK notes that an abnormal TSH result will always require at least one further test to establish the cause. T4 and T3 measurements, and sometimes thyroid antibody tests, fill in the rest of the picture.

The second question is structure: is there a lump, and if so, what does it look like? That is an ultrasound question. The American Thyroid Association describes thyroid nodules as extremely common — by age 60, roughly half of all people have one that can be found by examination or imaging — and notes that over 90 percent of them are benign. The association also makes a point that surprises many patients: thyroid function tests are usually normal even when a nodule contains cancer, so a normal blood panel does not substitute for imaging, and imaging does not substitute for the blood panel.

The ATA describes ultrasound as the key tool for nodule evaluation because it can distinguish a solid nodule from a fluid-filled cyst, measure size precisely, identify features that are more frequently associated with cancer, find nodules too small to feel, and track whether a known nodule is growing or shrinking over time. When a nodule's features meet criteria for sampling, fine-needle aspiration provides cells for a pathologist to examine.

At the Busan center, the thyroid pathway mirrors that structure directly: precision thyroid ultrasound to assess the gland's shape, size, and nodule characteristics — including whether a nodule is solid or cystic — combined with TSH, Free T4, and T3 blood testing for function. Neither thyroid nor breast ultrasound requires fasting, which makes them easy to slot into a longer screening morning.

A Word of Balance on Thyroid Screening

Because thyroid nodules are so common and so often harmless, the more useful framing is that a thyroid ultrasound result needs interpretation rather than reflex action. A small, low-risk nodule may reasonably be watched rather than immediately sampled.

The American Thyroid Association is explicit about this. It describes nodules that are benign on fine-needle aspiration, or too small to biopsy, as candidates for close monitoring — ultrasound every 6 to 12 months plus an annual physical examination — rather than automatic removal. Surgery becomes the recommendation when a nodule continues to grow or develops concerning ultrasound features during follow-up, or when biopsy indicates cancer. The association also notes that a benign biopsy result carries a small residual chance of missing a cancer, generally under 3 percent, which is one reason follow-up imaging matters.

So if your report mentions a nodule, the useful next question is not "when is surgery" but "what are its features, and what is the follow-up interval."

Gynecologic Health: The Visit Is Not the Same as the Test

The American College of Obstetricians and Gynecologists draws a distinction that is easy to lose. A periodic well-woman visit is recommended on an ongoing basis even in years when individual components of it — cervical cancer screening in particular — are not due. ACOG describes the visit as a container for screening, evaluation, counseling, and immunizations chosen according to age and risk factors, rather than as a delivery mechanism for a single swab.

Cervical screening intervals have lengthened considerably as the evidence matured. ACOG's updated guidance describes cytology alone every three years for individuals aged 21 to 29, and clinician-collected primary high-risk HPV testing every five years for those aged 30 to 65, with patient-collected HPV testing every three years as an option for average-risk patients in that age band. Routine screening is not recommended after a hysterectomy that removed the cervix in someone without a history of cervical cancer or high-grade precancer. The U.S. Preventive Services Task Force maintains a parallel recommendation statement on cervical cancer screening that readers can compare directly.

The point for anyone planning a screening trip is that cervical screening is unlikely to be due every year, while the consultation itself remains worth having annually. Questions about cycles, contraception, perimenopausal symptoms, pelvic pain, or family history do not follow a five-year schedule.

Yonsei Mirae IFC Medical Center's medical team includes Dr. Hwang Yeonhee, an obstetrics and gynecology specialist whose listed areas of practice are obstetrics and gynecology, women's health, and gynecologic care. She graduated from Dong-A University College of Medicine and completed her obstetrics and gynecology residency at Ilshin Christian Hospital. Her consultation hours run weekdays from 8:00 AM to 6:00 PM and Saturdays from 8:00 AM to 12:30 PM, Korea Standard Time. Because the center's screening programs are tiered — Basic, Silver, Gold, Premium, and Platinum — the gynecologic components included vary by the program selected, and the specific contents are worth confirming before you travel.

How It Fits Into a Single Visit

The center operates a one-day, one-stop screening model across a facility of approximately 6,600 square meters spanning the 2nd, 3rd, and 4th floors of IFC Mall at 133 Jeonpo-daero in Nam-gu, Busan, adjacent to the BIFC subway station. A comprehensive checkup generally runs about 3.5 to 4 hours; a national health insurance checkup runs 1.5 to 4 hours depending on which tests are included.

Two structural details matter specifically for women:

  • The facility uses separated male and female movement routes through the checkup areas, alongside a separate VIP patient flow. For examinations that involve changing clothes and partial undressing, that separation is not a cosmetic feature — it is the difference between a comfortable morning and an awkward one.
  • Breast and thyroid ultrasound require no fasting, but other components of a comprehensive program do. The center's general preparation guidance asks patients to avoid strenuous exercise, overwork, and alcohol beforehand, and to fast after 9 PM the night before the checkup. Procedures such as colonoscopy carry additional preparation requirements.

Health screening hours are Monday through Friday, 7:30 AM to 4:30 PM, and Saturday, 7:30 AM to 12:30 PM, with the center closed on Sundays and public holidays. For international patients, the center runs a dedicated international medical center with a foreign-patient coordinator, English and Chinese interpretation, and examination reports, doctor's notes, and medical records prepared in English and Chinese — which matters if you intend to hand the results to a physician back home. You can arrange a visit through the clinic's contact page.

What Happens If Something Turns Up

This is the question that actually keeps people from booking, and it deserves a direct answer.

When imaging identifies something that needs a tissue diagnosis, the center offers breast and thyroid biopsy under its Breast and Thyroid Care line. Most breast and thyroid needle biopsies are performed under local anesthesia as outpatient procedures, and pathology results take longer to return than imaging results because the specimen has to be processed and examined. A biopsy result describes the lesion that was sampled; it is not a statement about the rest of the organ.

For findings that need care beyond the center's scope, Yonsei Mirae IFC operates a One-Step referral system that connects patients to the relevant department or to a higher-level general hospital, with prescription and treatment services and step-by-step follow-up management. Result consultations are available by phone, which is a meaningful detail for anyone who will have flown home before every report is finalized. The center was founded in 2021, performs approximately 50,000 checkups annually, and is a Registered Medical Institution for Attracting Foreign Patients certified by Korea's Ministry of Health and Welfare — background you can read more about on the center's about page.

The Bottom Line

  • Women's screening is three distinct evaluations — breast, thyroid, and gynecologic — bundled for convenience rather than because they share underlying biology; each has its own recommended schedule.
  • The USPSTF recommends mammography every two years from age 40 to 74, while the American Cancer Society describes 40 to 44 as optional, 45 to 54 as annual, and 55 onward as a transition to biennial screening.
  • Thyroid assessment answers two separate questions: blood tests such as TSH, Free T4, and T3 measure function, while ultrasound examines structure and nodule characteristics. A normal blood panel does not rule out a nodule.
  • ACOG recommends an ongoing well-woman visit even in years when cervical screening is not due, with cytology every three years for ages 21 to 29 and primary HPV testing every five years for ages 30 to 65.
  • At Yonsei Mirae IFC Medical Center, these components sit inside a one-day, one-stop program with AI-assisted 3D mammography, breast and thyroid ultrasound, biopsy capability, an obstetrics and gynecology specialist, and separated female patient routes.

Frequently Asked Questions

Can breast, thyroid, and gynecologic screening really be done in one morning?

Yes, within a single comprehensive visit. The center's comprehensive checkup generally takes about 3.5 to 4 hours, with examinations performed according to the program selected. Breast and thyroid imaging are relatively quick components within that window.

Do I need to fast before breast and thyroid imaging?

Not for those examinations specifically — the center states that fasting is not required when only thyroid, breast, carotid, or lower-abdominal ultrasound is performed. However, most comprehensive programs include blood work and other tests that do require fasting after 9 PM the night before, so follow the preparation instructions for your full program rather than for one test.

What if I am breastfeeding?

Mammography is not performed during breastfeeding. Breast ultrasound is used instead, and it can also be performed during pregnancy. Tell the medical team about pregnancy or breastfeeding when you complete the health questionnaire so the appropriate examination is selected.

Does a thyroid nodule mean I have cancer?

Usually not. The American Thyroid Association reports that over 90 percent of thyroid nodules are benign, and that nodules are extremely common, with roughly half of people having one by age 60. Ultrasound features, nodule size, and changes over time determine whether sampling is recommended or whether periodic monitoring is the appropriate course.

How often do I actually need cervical screening?

Less often than many people assume. ACOG describes cytology every three years for ages 21 to 29 and primary high-risk HPV testing every five years for ages 30 to 65 at average risk. The periodic well-woman consultation is still recommended in the intervening years, because it covers far more than cervical screening alone.

Will I be able to understand my results if I do not speak Korean?

The center provides English and Chinese interpretation through a dedicated international medical center and foreign-patient coordinator, and prepares examination reports, doctor's notes, and medical records in English and Chinese. Result consultations are also available by phone after you return home.

What happens if an abnormal result comes back after I have left Korea?

The center provides follow-up management including phone-based result consultations, and operates a One-Step referral system that connects patients with abnormal findings to relevant departments or to higher-level general hospitals. Bringing the English-language report to your own physician is the sensible next step, since they hold the rest of your medical history.

How do I know which program includes which tests?

Screening programs are tiered from Basic through Platinum, and the contents differ by tier. Because the components vary, confirm the exact examination list and current costs with the center before booking, particularly if you are traveling specifically for a breast, thyroid, or gynecologic evaluation.

This article is for general informational purposes and does not constitute individualized medical advice, and it is not a self-diagnosis tool. Screening options, test selection, and the meaning of any result can only be determined through consultation with a qualified physician.

More Articles

Continue reading our clinical guides.

View All
Is a 3.0T MRI Health Screening Safe? Radiation, Contrast

Is a 3.0T MRI Health Screening Safe? Radiation, Contrast

What MRI screening safety really involves: no ionizing radiation, gadolinium contrast risks, implant disclosure, pregnancy advice and claustrophobia help.

Learn More

Learn More
Low-Dose CT Lung Cancer Screening in Korea: Who Qualifies

Low-Dose CT Lung Cancer Screening in Korea: Who Qualifies

Who should consider low-dose CT lung screening in Korea: age and smoking criteria from the USPSTF and ACS, trial evidence, risks, and follow-up planning.

Learn More

Learn More
Combining a Health Checkup and GI Screening in Korea

Combining a Health Checkup and GI Screening in Korea

How to combine a health checkup and colonoscopy in Korea on one trip: what the shared fast covers, how the day runs, and real limits of a combined visit.

Learn More

Learn More

Yonsei Mirae IFC Medical Center

Comprehensive 6,600㎡ health screening and specialist medical center on 2F–4F of IFC Mall, 133 Jeonpo-daero, Nam-gu, Busan. Dedicated one-day checkups and specialist care for domestic and international patients.

Departments & Programs

SpecialtiesServicesMedical TeamSpecial OffersMedical Articles

Patient Guide

About UsHow It WorksPatient ReviewsPress & Media

Information & Legal

Contact & LocationSite SearchPrivacy PolicyRefund & Cancellation PolicyTerms of Use

© Yonsei Mirae IFC Medical Center (Business Reg. No. 320-46-00824). All rights reserved.

Clinical examination findings and treatment outcomes vary by individual health status. Please consult a board-certified specialist regarding indications and potential side effects.